Enzo Biochem (ENZ) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Cost of clinical laboratory services: 10.9M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Financial Fact:
Cost of clinical laboratory services: 10.9M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $24.6 million versus the consensus estimate of $24.43 million.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
